Related references
Note: Only part of the references are listed.The role of microRNAs in solving COVID-19 puzzle from infection to therapeutics: A mini-review
Sujay Paul et al.
VIRUS RESEARCH (2022)
Evaluation of miR-200c-3p and miR-421-5p levels during immune responses in the admitted and recovered COVID-19 subjects
Shahrokh Abdolahi et al.
INFECTION GENETICS AND EVOLUTION (2022)
The inhibitory effect of a coronavirus spike protein fragment with ACE2
Emanuel K. Peter et al.
BIOPHYSICAL JOURNAL (2021)
Plasma ACE2 activity is persistently elevated following SARS-CoV-2 infection: implications for COVID-19 pathogenesis and consequences
Sheila K. Patel et al.
EUROPEAN RESPIRATORY JOURNAL (2021)
A historical perspective on ACE2 in the COVID-19 era
Vivek Bhalla et al.
JOURNAL OF HUMAN HYPERTENSION (2021)
Decreased serum levels of the inflammaging marker miR-146a are associated with clinical non-response to tocilizumab in COVID-19 patients
Jacopo Sabbatinelli et al.
MECHANISMS OF AGEING AND DEVELOPMENT (2021)
MicroRNA Mimics or Inhibitors as Antiviral Therapeutic Approaches Against COVID-19
Christine Hum et al.
DRUGS (2021)
A dramatic rise in serum ACE2 activity in a critically ill COVID-19 patient
Bela Nagy et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2021)
High serum miR-421 is associated with metabolic dysregulation and inflammation in patients with metabolic syndrome
Aecio A. Braga et al.
EPIGENOMICS (2021)
Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
Gabor Kriszta et al.
FRONTIERS IN PHARMACOLOGY (2021)
The role of miRNAs in COVID-19 disease
Mona Fani et al.
FUTURE VIROLOGY (2021)
Circulating Soluble ACE2 and Upstream microRNA Expressions in Serum of Type 2 Diabetes Mellitus Patients
Noha Mousaad Elemam et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Epidemiology of asymptomatic and symptomatic Coronavirus Disease 2019 confirmed cases in the Emirate of Abu Dhabi, United Arab Emirates Observational study
Farida Al Hosani et al.
MEDICINE (2021)
Altered microRNA expression in COVID-19 patients enables identification of SARS-CoV-2 infection
Ryan J. Farr et al.
PLOS PATHOGENS (2021)
Expression of ACE2, Soluble ACE2, Angiotensin I, Angiotensin II and Angiotensin-(1-7) Is Modulated in COVID-19 Patients
Ikram Omar Osman et al.
FRONTIERS IN IMMUNOLOGY (2021)
Plasma ACE2 predicts outcome of COVID-19 in hospitalized patients
Tue W. Kragstrup et al.
PLOS ONE (2021)
Serum levels of ACE2 are higher in patients with obesity and diabetes
Valur Emilsson et al.
OBESITY SCIENCE & PRACTICE (2021)
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Daniel Wrapp et al.
SCIENCE (2020)
Computational Design of ACE2-Based Peptide Inhibitors of SARS-CoV-2
Yanxiao Han et al.
ACS NANO (2020)
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
Markus Hoffmann et al.
CELL (2020)
Aging, Male Sex, Obesity, and Metabolic Inflammation Create the Perfect Storm for COVID-19
Franck Mauvais-Jarvis
DIABETES (2020)
Impact of diabetes mellitus on clinical outcomes in patients affected by Covid-19
Celestino Sardu et al.
CARDIOVASCULAR DIABETOLOGY (2020)
Epigenetic Regulator miRNA Pattern Differences Among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 World-Wide Isolates Delineated the Mystery Behind the Epic Pathogenicity and Distinct Clinical Characteristics of Pandemic COVID-19
Md. Abdullah-Al-Kamran Khan et al.
FRONTIERS IN GENETICS (2020)
Expression Profile of SARS-CoV-2 Host Receptors in Human Pancreatic Islets Revealed Upregulation of ACE2 in Diabetic Donors
Jalal Taneera et al.
BIOLOGY-BASEL (2020)
Expression of ACE2, the SARS-CoV-2 Receptor, in Lung Tissue of Patients With Type 2 Diabetes
Sara R. A. Wijnant et al.
DIABETES (2020)
Human recombinant soluble ACE2 in severe COVID-19
Alexander Zoufaly et al.
LANCET RESPIRATORY MEDICINE (2020)
De novo design of potent and resilient hACE2 decoys to neutralize SARS-CoV-2
Thomas W. Linsky et al.
SCIENCE (2020)
Age and sex differences in soluble ACE2 may give insights for COVID-19
Per Sward et al.
CRITICAL CARE (2020)
Plasma levels of soluble ACE2are associated with sex, Metabolic Syndrome, and its biomarkers in a large cohort, pointing to a possible mechanism for increased severity in COVID-19
Sergey A. Kornilov et al.
CRITICAL CARE (2020)
Prediabetes and diabetes prevalence and risk factors comparison between ethnic groups in the United Arab Emirates
Rifat Hamoudi et al.
SCIENTIFIC REPORTS (2019)
Combination of Circulating miRNA-320a/b and D-Dimer Improves Diagnostic Accuracy in Deep Vein Thrombosis Patients
Zhiyun Jiang et al.
MEDICAL SCIENCE MONITOR (2018)
Small and Long Non-Coding RNAs: Novel Targets in Perspective Cancer Therapy
Chi Han Li et al.
CURRENT GENOMICS (2015)
Tumor necrosis factor-α convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)
DW Lambert et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis
I Hamming et al.
JOURNAL OF PATHOLOGY (2004)